2-indolinone derivatives as multi-target protein kinase inhibitors and histone deacetylase inhibitors
申请人:Shenzhen Chipscreen Biosciences Ltd.
公开号:US08158656B2
公开(公告)日:2012-04-17
The present invention relates to 2-indolinone derivatives which are capable of inhibiting protein kinases and histone deacetylases. The compounds of this invention are therefore useful in treating diseases associated with abnormal protein kinase activities or abnormal histone deacetylase activities. Pharmaceutical compositions comprising these compounds, methods of treating diseases utilizing pharmaceutical compositions comprising these compounds, and methods of preparing these compounds are also disclosed.
本发明涉及能够抑制蛋白激酶和组蛋白去乙酰化酶的2-吲哚酮衍生物。因此,本发明的化合物在治疗与异常蛋白激酶活性或异常组蛋白去乙酰化酶活性相关的疾病方面是有用的。本发明还公开了包含这些化合物的制药组合物,利用包含这些化合物的制药组合物治疗疾病的方法以及制备这些化合物的方法。